JP2014529613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014529613A5 JP2014529613A5 JP2014527357A JP2014527357A JP2014529613A5 JP 2014529613 A5 JP2014529613 A5 JP 2014529613A5 JP 2014527357 A JP2014527357 A JP 2014527357A JP 2014527357 A JP2014527357 A JP 2014527357A JP 2014529613 A5 JP2014529613 A5 JP 2014529613A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- seq
- haloalkyl
- amyloid beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527584P | 2011-08-25 | 2011-08-25 | |
| US61/527,584 | 2011-08-25 | ||
| US201161527963P | 2011-08-26 | 2011-08-26 | |
| US61/527,963 | 2011-08-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014529613A JP2014529613A (ja) | 2014-11-13 |
| JP2014529613A5 true JP2014529613A5 (cg-RX-API-DMAC7.html) | 2016-03-31 |
Family
ID=47747106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527357A Pending JP2014529613A (ja) | 2011-08-25 | 2012-08-27 | 神経変性疾患を治療する組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140378460A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2747768A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2014529613A (cg-RX-API-DMAC7.html) |
| CN (2) | CN107260726A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2012298617B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014004416A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2846611A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1202246A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL231158A0 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2014111078A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013029060A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013029057A2 (en) * | 2011-08-25 | 2013-02-28 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| ES2769780T3 (es) * | 2013-10-28 | 2020-06-29 | Univ Drexel | Tratamientos novedosos para los trastornos de atención y cognitivos y para la demencia asociada a un trastorno neurodegenerativo |
| WO2015116923A1 (en) | 2014-01-31 | 2015-08-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| US10457642B2 (en) | 2015-05-04 | 2019-10-29 | The Trustees Of The University Of Pennsylvania | 211-astatine containing radiotherapeutics for the treatment of cancer |
| US11617734B2 (en) * | 2015-07-22 | 2023-04-04 | Anavex Life Sciences Corp. | Enantiomers of A2-73, analogues, and sigma agonist activity |
| CN110662532A (zh) * | 2017-04-03 | 2020-01-07 | 加利福尼亚大学董事会 | 用于跨血脑屏障、透粘膜和经皮药物递送的可变形的纳米级媒介物(dnvs) |
| CN106986836A (zh) * | 2017-04-26 | 2017-07-28 | 毛阿龙 | 具有抗细菌活性的新型速激肽拮抗剂的制备方法 |
| ES3063712T3 (en) | 2017-05-15 | 2026-04-20 | Cognition Therapeutics Inc | Compositions for treating neurodegenerative diseases |
| US12352719B2 (en) | 2019-09-20 | 2025-07-08 | KYCERA AVX Components Corporation | Somatic cell-based electrical biosensor |
| WO2021064610A1 (en) * | 2019-10-01 | 2021-04-08 | Ac Immune Sa | Micro-radiobinding assays for ligand screening |
| CN116867488A (zh) * | 2020-12-11 | 2023-10-10 | 考格尼申治疗股份有限公司 | 用于治疗干性老年性黄斑变性(amd)的组合物 |
| CN112816533A (zh) * | 2020-12-31 | 2021-05-18 | 商丘师范学院 | 一种铜纳米簇作为电化学信号探针的β-淀粉样蛋白寡聚体传感器 |
| WO2026030341A1 (en) | 2024-07-29 | 2026-02-05 | Cognition Therapeutics, Inc. | Zervimesine for treating neurodegenerative disease |
| WO2026136732A1 (en) | 2024-12-18 | 2026-06-25 | Cognition Therapeutics, Inc. | Compositions and methods for the treatment of dementia with lewy bodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997030038A1 (en) * | 1996-02-15 | 1997-08-21 | Mitsubishi Chemical Corporation | Diarylsultam derivatives |
| EP1635805A4 (en) * | 2003-06-12 | 2007-08-08 | Ms Science Corp | SIGMA RECEPTOR LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RE-ESTABLISHMENT |
| US20080153917A1 (en) * | 2004-09-10 | 2008-06-26 | Ucb Pharma, S.A. | Sigma Receptor Ligands |
| ITRM20060007A1 (it) * | 2006-01-05 | 2007-07-06 | Univ Bari | Recettore sigma-2 metodo di screening di ligandi specifici e uso degli stessi in metodi diagnostici o terapeutici |
| US20100029654A1 (en) * | 2006-03-23 | 2010-02-04 | Mount Sinai School Of Medicine | Cardiovascular compositions and use of the same for the treatment of alzheimer's disease |
| WO2010088450A2 (en) * | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| WO2010118055A1 (en) * | 2009-04-09 | 2010-10-14 | Cognition Therapeutics, Inc. | Inhibitors of cognitive decline |
| RU2012107457A (ru) * | 2009-07-31 | 2013-09-10 | Когнишн Терапьютикс, Инк. | Ингибиторы ухудшения когнитивных способностей |
| US20130071330A1 (en) * | 2010-02-26 | 2013-03-21 | Susan Catalano | Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
-
2012
- 2012-08-27 US US14/241,026 patent/US20140378460A1/en not_active Abandoned
- 2012-08-27 WO PCT/US2012/052578 patent/WO2013029060A2/en not_active Ceased
- 2012-08-27 CN CN201710491989.4A patent/CN107260726A/zh active Pending
- 2012-08-27 BR BR112014004416A patent/BR112014004416A2/pt not_active IP Right Cessation
- 2012-08-27 AU AU2012298617A patent/AU2012298617B2/en not_active Ceased
- 2012-08-27 EP EP12825341.6A patent/EP2747768A4/en not_active Withdrawn
- 2012-08-27 RU RU2014111078/15A patent/RU2014111078A/ru not_active Application Discontinuation
- 2012-08-27 JP JP2014527357A patent/JP2014529613A/ja active Pending
- 2012-08-27 CN CN201280052588.4A patent/CN104053436A/zh active Pending
- 2012-08-27 CA CA2846611A patent/CA2846611A1/en not_active Abandoned
- 2012-08-27 HK HK15102753.6A patent/HK1202246A1/xx unknown
-
2014
- 2014-02-25 IL IL231158A patent/IL231158A0/en unknown
-
2016
- 2016-06-30 AU AU2016204554A patent/AU2016204554A1/en not_active Abandoned
-
2017
- 2017-04-21 US US15/493,979 patent/US20170349554A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2649155T3 (es) | Anticuerpos anti-OX40 y procedimientos de uso de los mismos | |
| JP2014524482A5 (cg-RX-API-DMAC7.html) | ||
| Fang et al. | Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response | |
| JP2019059786A5 (cg-RX-API-DMAC7.html) | ||
| ES2865023T3 (es) | Anticuerpo anti-lipoarabinomanano e inmunoensayo para detectar la infección por bacilos acidorresistentes usando el anticuerpo | |
| JP2014508748A5 (cg-RX-API-DMAC7.html) | ||
| CN105050621B (zh) | 防止和治疗多发性硬化症的方法 | |
| JP6768728B2 (ja) | ヒト抗体ならびに神経疾患の処置のためのその診断的および治療的使用 | |
| RU2017105515A (ru) | Сигнальная система | |
| RU2014111078A (ru) | Композиции и способы для лечения нейродегенеративного заболевания | |
| HRP20140240T4 (hr) | Monoklonalna antitijela protiv amiloidnih beta proteina i njihova upotreba | |
| JP2013538796A5 (cg-RX-API-DMAC7.html) | ||
| CN105979962A (zh) | 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法 | |
| JP2016509585A5 (cg-RX-API-DMAC7.html) | ||
| JP2013506425A5 (cg-RX-API-DMAC7.html) | ||
| CN104379167B (zh) | 用于中风和缺血或缺血性病况的人抗体及其特异性结合序列 | |
| EP3307320A2 (en) | Stable formulations of humanized anti-tau antibody | |
| JP2017511377A5 (cg-RX-API-DMAC7.html) | ||
| CN101374514A (zh) | 神经元烟碱性受体配体和它们的用途 | |
| Cheng et al. | The glomerulus–a view from the outside–the podocyte | |
| Ciprés-Flores et al. | Beta-blockers and salbutamol limited emotional memory disturbance and damage induced by orchiectomy in the rat hippocampus | |
| JP2017520562A5 (cg-RX-API-DMAC7.html) | ||
| Jun et al. | Clinical features and treatment outcome of primary systemic light‐chain amyloidosis in Korea: Results of multicenter analysis | |
| Hori et al. | Why does the progression of Alzheimer’s disease accelerate | |
| Ma et al. | Expression of noradrenergic α1, serotoninergic 5HT2a and dopaminergic D2 receptors on neurons activated by typical and atypical antipsychotic drugs |